ABVC Biopharma IncNASDAQ:ABVC
- LAST PRICE1.0200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.9800/ 1
- Ask / Lots1.0700/ 8
- Open / Previous Close1.1500 / 1.0200
- Day Range
- 52 Week Range
- Volume1,777,147
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ABVC |
|---|---|---|
| 09:32 ET | 64197 | 1.1206 |
| 09:34 ET | 59096 | 1.1 |
| 09:36 ET | 31833 | 1.07 |
| 09:38 ET | 5963 | 1.08 |
| 09:39 ET | 3011 | 1.1 |
| 09:41 ET | 3275 | 1.105 |
| 09:43 ET | 10463 | 1.1003 |
| 09:45 ET | 8812 | 1.09 |
| 09:48 ET | 12306 | 1.07 |
| 09:50 ET | 30762 | 1.055 |
| 09:52 ET | 15478 | 1.0599 |
| 09:54 ET | 5469 | 1.06 |
| 09:56 ET | 12522 | 1.07 |
| 09:57 ET | 7979 | 1.0595 |
| 09:59 ET | 7563 | 1.0501 |
| 10:01 ET | 3002 | 1.07 |
| 10:03 ET | 5566 | 1.0666 |
| 10:06 ET | 3058 | 1.0662 |
| 10:08 ET | 15256 | 1.05 |
| 10:10 ET | 34188 | 1.03 |
| 10:12 ET | 13424 | 1.02 |
| 10:14 ET | 6523 | 1.025 |
| 10:15 ET | 13149 | 1.035 |
| 10:17 ET | 2532 | 1.04 |
| 10:19 ET | 4300 | 1.05 |
| 10:21 ET | 1850 | 1.04 |
| 10:24 ET | 2670 | 1.05 |
| 10:26 ET | 1300 | 1.04 |
| 10:28 ET | 3141 | 1.0499 |
| 10:30 ET | 895 | 1.05 |
| 10:32 ET | 9378 | 1.04 |
| 10:33 ET | 1587 | 1.045 |
| 10:35 ET | 4564 | 1.04 |
| 10:37 ET | 1400 | 1.04 |
| 10:39 ET | 1345 | 1.04 |
| 10:42 ET | 10897 | 1.04 |
| 10:44 ET | 4937 | 1.04 |
| 10:46 ET | 900 | 1.049 |
| 10:48 ET | 100 | 1.03 |
| 10:50 ET | 700 | 1.048 |
| 10:51 ET | 530 | 1.0313 |
| 10:53 ET | 200 | 1.05 |
| 10:55 ET | 1562 | 1.05 |
| 10:57 ET | 320 | 1.04 |
| 11:00 ET | 400 | 1.05 |
| 11:02 ET | 185 | 1.04 |
| 11:04 ET | 6474 | 1.0494 |
| 11:06 ET | 1585 | 1.0304 |
| 11:09 ET | 305 | 1.03 |
| 11:11 ET | 100 | 1.05 |
| 11:13 ET | 300 | 1.04 |
| 11:15 ET | 460 | 1.05 |
| 11:18 ET | 4640 | 1.05 |
| 11:20 ET | 100 | 1.05 |
| 11:22 ET | 2434 | 1.05 |
| 11:24 ET | 100 | 1.04 |
| 11:26 ET | 207 | 1.05 |
| 11:27 ET | 600 | 1.05 |
| 11:29 ET | 1900 | 1.04 |
| 11:31 ET | 600 | 1.05 |
| 11:33 ET | 865 | 1.05 |
| 11:36 ET | 100 | 1.05 |
| 11:38 ET | 200 | 1.05 |
| 11:40 ET | 970 | 1.0499 |
| 11:42 ET | 100 | 1.05 |
| 11:44 ET | 405 | 1.05 |
| 11:45 ET | 1000 | 1.05 |
| 11:47 ET | 1624 | 1.05 |
| 11:49 ET | 100 | 1.05 |
| 11:58 ET | 100 | 1.06 |
| 12:00 ET | 500 | 1.0508 |
| 12:02 ET | 600 | 1.05 |
| 12:03 ET | 100 | 1.05 |
| 12:05 ET | 440 | 1.05 |
| 12:07 ET | 600 | 1.05 |
| 12:12 ET | 510 | 1.04 |
| 12:14 ET | 600 | 1.03 |
| 12:16 ET | 100 | 1.03 |
| 12:18 ET | 100 | 1.05 |
| 12:20 ET | 1230 | 1.035 |
| 12:21 ET | 800 | 1.035 |
| 12:23 ET | 1098 | 1.03 |
| 12:25 ET | 7600 | 1.035 |
| 12:27 ET | 7830 | 1.035 |
| 12:30 ET | 3306 | 1.035 |
| 12:34 ET | 8319 | 1.02 |
| 12:38 ET | 2260 | 1.02 |
| 12:39 ET | 939 | 1.02 |
| 12:43 ET | 35717 | 1.01 |
| 12:45 ET | 600 | 1.01 |
| 12:50 ET | 6998 | 1.01 |
| 12:52 ET | 7608 | 1.02 |
| 12:54 ET | 200 | 1.01 |
| 12:56 ET | 900 | 1.02 |
| 12:57 ET | 100 | 1.02 |
| 01:01 ET | 400 | 1.025 |
| 01:03 ET | 200 | 1.02 |
| 01:06 ET | 3094 | 1.02 |
| 01:08 ET | 4849 | 1.025 |
| 01:10 ET | 400 | 1.03 |
| 01:12 ET | 1550 | 1.025 |
| 01:14 ET | 1653 | 1.03 |
| 01:15 ET | 535 | 1.025 |
| 01:17 ET | 200 | 1.025 |
| 01:19 ET | 100 | 1.03 |
| 01:21 ET | 100 | 1.03 |
| 01:24 ET | 600 | 1.03 |
| 01:26 ET | 1200 | 1.025 |
| 01:28 ET | 200 | 1.03 |
| 01:30 ET | 200 | 1.03 |
| 01:32 ET | 957 | 1.0201 |
| 01:35 ET | 1300 | 1.03 |
| 01:37 ET | 100 | 1.04 |
| 01:39 ET | 645 | 1.03 |
| 01:42 ET | 227 | 1.03 |
| 01:46 ET | 755 | 1.03 |
| 01:48 ET | 100 | 1.02 |
| 01:51 ET | 135 | 1.025 |
| 01:53 ET | 341 | 1.02 |
| 01:55 ET | 400 | 1.025 |
| 02:04 ET | 155 | 1.025 |
| 02:06 ET | 100 | 1.02 |
| 02:08 ET | 1304 | 1.03 |
| 02:09 ET | 105 | 1.025 |
| 02:11 ET | 285 | 1.025 |
| 02:15 ET | 100 | 1.02 |
| 02:18 ET | 1116 | 1.03 |
| 02:20 ET | 110 | 1.02 |
| 02:22 ET | 210 | 1.03 |
| 02:26 ET | 300 | 1.0201 |
| 02:27 ET | 200 | 1.03 |
| 02:31 ET | 1446 | 1.03 |
| 02:33 ET | 610 | 1.03 |
| 02:38 ET | 400 | 1.03 |
| 02:40 ET | 3213 | 1.02 |
| 02:44 ET | 1100 | 1.02 |
| 02:45 ET | 142 | 1.03 |
| 02:47 ET | 120 | 1.02 |
| 02:51 ET | 880 | 1.02 |
| 02:54 ET | 898 | 1.03 |
| 02:56 ET | 100 | 1.02 |
| 02:58 ET | 3500 | 1.02 |
| 03:00 ET | 970 | 1.02 |
| 03:02 ET | 1420 | 1.02 |
| 03:03 ET | 1797 | 1.02 |
| 03:05 ET | 3351 | 1.01 |
| 03:07 ET | 500 | 1.02 |
| 03:09 ET | 400 | 1.02 |
| 03:12 ET | 300 | 1.01 |
| 03:16 ET | 200 | 1.0299 |
| 03:18 ET | 200 | 1.01 |
| 03:20 ET | 611 | 1.02 |
| 03:21 ET | 100 | 1.02 |
| 03:23 ET | 1100 | 1.02 |
| 03:25 ET | 1893 | 1.01 |
| 03:27 ET | 100 | 1.01 |
| 03:30 ET | 2690 | 1.0197 |
| 03:32 ET | 100 | 1.01 |
| 03:36 ET | 2614 | 1.01 |
| 03:38 ET | 3031 | 1.01 |
| 03:41 ET | 5804 | 1.01 |
| 03:43 ET | 1552 | 1.01 |
| 03:45 ET | 1200 | 1.015 |
| 03:48 ET | 8920 | 1.015 |
| 03:50 ET | 6784 | 1.015 |
| 03:52 ET | 615 | 1.015 |
| 03:54 ET | 1105 | 1.02 |
| 03:56 ET | 5795 | 1.02 |
| 03:57 ET | 1597 | 1.02 |
| 03:59 ET | 4872 | 1.02 |
Yesterday
Apr 10, 2024
Mar 26, 2024
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M, from 8:30AM ET on Tuesday Mar 26, 2024 by Dow Jones
8:30AM ET on Tuesday Mar 26, 2024 by Dow Jones
Mar 21, 2024
Mar 19, 2024
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine, from 8:30AM ET on Tuesday Mar 19, 2024 by Dow Jones
8:30AM ET on Tuesday Mar 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ABVC Biopharma Inc | 11.8M | -0.4x | --- |
Eterna Therapeutics Inc | 11.7M | -0.5x | --- |
Mira Pharmaceuticals Inc | 11.7M | -1.0x | --- |
Benitec Biopharma Inc | 12.4M | -0.4x | --- |
Organovo Holdings Inc | 11.5M | -0.5x | --- |
Aslan Pharmaceuticals Ltd | 11.1M | -0.2x | --- |
Company Information
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development products and technologies to combat various diseases. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1701 is a vitreous substitute for vitrectomy. Its ABV-1519 is used for the treatment of non-small cell lung cancer. ABV-1703 is a drug for advanced, inoperable, or metastatic pancreatic cancer. The Company develops drugs and medical devices derived from plants.
Contact Information
- Headquarters
- 44370 Old Warm Springs BlvdFREMONT, CA, United States 94538-6148
- Phone
- 510-668-0881
- Fax
- ---
Executives
- Chairman of the Board, Chief Business Officer
- Eugene Jiang
- Chief Executive Officer
- Uttam Patil
- Chief Financial Officer, Principal Accounting Officer
- Leeds Chow
- Chief Scientific Officer, Chief Strategy Officer, Director
- Tsung-Shann Jiang
- Director
- Chang-Jen Jiang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.8M |
|---|---|
Revenue (TTM) | $152.4K |
Shares Outstanding | 10.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-2.52 |
Book Value | $1.06 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 77.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,390.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
